We are excited to announce two new partnerships with Airlink and the UCSF-Stanford Pediatric Device Consortium. Both partnerships will help Neonatal Rescue further our mission to reduce infant mortality.
The UCSF-Stanford Pediatric Device Consortium is “funded by the FDA’s Office of Orphan Products Development to help pediatric device innovators accelerate high-value, high-impact solutions towards commercialization and clinical use” (UCSF-Stanford Pediatric Device Consortium, 2022). On October 7, Rob Brown, Neonatal Rescue’s CEO and Janelle Gardiner, VP of Clinical Operations, traveled to San Francisco to compete at the 4th annual Michael R. Harrison Innovation Symposium. We are honored to report that we received the silver award. “In addition to [$25,000] in funding (thanks to support from FDA and other matching funds), the award involves mentoring, advising, and subsequent tracking of project progress, including regular progress and spending updates” (UCSF-Stanford Pediatric Device Consortium, 2022).
Airlink works to address ongoing needs in the developing world, such as access to clean water, food, shelter, and medical aid to improve community resiliency through aviation and logistics partners to transport relief workers and emergency supplies for reputable non-governmental organizations (NGOs). Through our partnership with Airlink, we will work with airline and logistics partners to help deliver Neolife and Adultlife ventilators to our programs.
We are excited to work with our new partners and expand our work to new areas of the world.